Clinical implications of hepatitis B virus variants

Journal of the Formosan Medical Association

Volumn 109, Issue 5, 2010, Pages 321-325

  Lin, Chih Lin ^a,b   Kao, Jia Horng ^c,d,e  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL CHENGCHI UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e Hepatitis Research Center   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; VIRUS DNA; CORE PROTEIN;

ARTICLE; CHRONIC HEPATITIS; DISEASE COURSE; GENE DELETION; GENE MUTATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; OUTCOME ASSESSMENT; PROMOTER REGION; VIRUS CARRIER; VIRUS GENE; VIRUS GENOME; VIRUS MUTANT; VIRUS MUTATION; CLASSIFICATION; GENETIC VARIABILITY; GENETICS; MUTATION; VIROLOGY;

GENETIC VARIATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MUTATION; PROMOTER REGIONS, GENETIC; SEQUENCE DELETION; VIRAL CORE PROTEINS;

EID: 77955870150     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/S0929-6646(10)60059-9     Document Type: Article

References (36)

1. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002;2:395-403.
2. Robinson WS. The genome of hepatitis B virus. Annu Rev Microbiol 1977;31:357-77.
3. Ganem D, Varmus HE. The molecular biology of the hepatitis B viruses. Annu Rev Biochem 1987;56:651-93.
4. Lau JY, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet 1993;342:1335-40. (Pubitemid 23345183)
5. Hunt CM, McGill JM, Allen MI, et al. Clinical relevance of hepatitis B viral mutations. Hepatology 2000;31:1037-44. (Pubitemid 30233226)
6. Kao JH. Role of viral factors in the natural course and therapy of chronic hepatitis B. Hepatol Int 2007;1: 415-30.
7. Okamoto H, Imai M, Kametani M, et al. Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission. Jpn J Exp Med 1987;57:231-6.
8. Kao JH, Chen DS. HBV genotypes: epidemiology and implications regarding natural history. Curr Hepat Rep 2006; 5:5-13.
9. Kao JH. Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol Hepatol 2002; 17:643-50.
10. Chotiyaputta W, Lok AS. Hepatitis B virus variants. Nat Rev Gastroenterol Hepatol 2009;6:453-62.
11. Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 2006;43(Suppl 1):S173-81.
12. Lin CL, Kao JH. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B. J Biomed Sci 2008;15:137-45.
13. Hadziyannis SJ, Vassilopoulos D. Hepatitis B e antigennegative chronic hepatitis B. Hepatology 2001;34:617-24.
14. Bonino F, Brunetto MR. Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B: an overview. J Hepatol 2003;39:S160-3. (Pubitemid 37222665)
15. Tong S, Kim KH, Chante C, et al. Hepatitis B virus e antigen variants. Int J Med Sci 2005;2:2-7. (Pubitemid 40944952)
16. Carman WF, Jacyna MR, Hadziyannis S, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989;2:588-91. (Pubitemid 19216208)
17. Okamoto H, Yotsumoto S, Akahane Y, et al. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 1990;64:1298-303. (Pubitemid 20087771)
18. Okamoto H, Tsuda F, Akahane Y, et al. Hepatitis B virus with mutations in the core promoter for an e antigennegative phenotype in carriers with antibody to e antigen. J Virol 1994;68:8102-10.
19. Kao JH, Chen PJ, Lai MY, et al. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 2003; 124:327-34.
20. Lin CL, Liao LY, Wang CS, et al. Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B. Liver Int 2005;25:564-70.
21. Liu CJ, Chen BF, Chen PJ, et al. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. J Infect Dis 2006;193: 1258-65.
22. Liu CJ, Chen BF, Chen PJ, et al. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study. J Infect Dis 2006;194:594-9.
23. Chen BF, Liu CJ, Jow GM, et al. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 2006;130:1153-68.
24. Liu S, Zhang H, Gu C, et al. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst 2009;101:1066-82.
25. Yang HI, Yeh SH, Chen PJ, et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 2008;100: 1134-43.
26. Yuen MF, Tanaka Y, Shinkai N, et al. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer Il/core promoter/precore regions and HBV DNA levels. Gut 2008;57: 98-102.
27. Chou YC, Yu MW, Wu CF, et al. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma. Gut 2008;57:91-7.
28. Gerken G, Kremsdorf D, Capel F, et al. Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection. Virology 1991;183:555-65.
29. Fernholz D, Stemler M, Brunetto M, et al. Replicating and virion secreting hepatitis B mutant virus unable to produce preS2 protein. J Hepatol 1991;13:S102-4.
30. Xu Z, Yen TSB. Intracellular retention of surface protein by a hepatitis B virus mutant that releases virion particles. J Virol 1996;70:133-40. (Pubitemid 126508778)
31. Fan YF, Lu CC, Chen WC, et al. Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection. Hepatology 2001;33:277-86.
32. Sugauchi F, Ohno T, Orito E, et al. Influence of hepatitis B virus genotypes on the development of pre-S deletions and advanced liver disease. J Med Virol 2003;70:537-44. (Pubitemid 36734717)
33. Lin CL, Wu PY, Chang WL, et al. Clinical significance of hepatitis B virus pre-S deletion mutants in patients with chronic hepatitis B virus infection: A case-control study. Gastroenterol J Taiwan 2009;26:171-9.
34. Lin CL, Liu CH, Chen Wendy, et al. Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. J Gastroenterol Hepatol 2007;22:1098-103.
35. Chen CH, Hung CH, Lee CM, et al. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Gastroenterology 2007;133:1466-74.
36. Fang ZL, Sabin CA, Dong BQ, et al. Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study. J Gen Virol 2008;89:2882-90.